✦ LIBER ✦

Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma

✍ Scribed by Y. Tsutsumi; J. Tanaka; T. Kawamura; T. Miura; H. Kanamori; S. Obara; M. Asaka; M. Imamura; N. Masauzi

Publisher: Springer
Year: 2004
Tongue: English
Weight: 106 KB
Volume: 83
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-003-0748-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute hepatic failure due to hepatosplen

Acute hepatic failure due to hepatosplenic B-cell non-Hodgkin's lymphoma in a patient infected with hepatitis C virus

✍ Masahide Yoshikawa; Yoshiko Yamane; Satoshi Yoneda; Shu Iwasawa; Kimio Nishimura 📂 Article 📅 1998 🏛 Springer Japan 🌐 English ⚖ 332 KB

P168 Hepatitis B virus reactivation in a

P168 Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with immuno-chemotherapy (including fludarabine and rituximab)

✍ Zs. Ujj; L. Rejtö; I. Tornai; A. Kiss; B. Telek; Gy. Reményi; P. Ilonczai; M. Ud 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

was longer on retreatment (11 months) than at first treatment (6 months). It is of special interest, that this patient was 83 years old when treated first with radioimmunotherapy and tolerated it on both occasions without side effects or severe cytopenias. In another patient with severe accompanying

Successful lamivudine therapy for post-c

Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature

✍ Y. Kawai; S. Ikegaya; M. Hata; M. Kawahito; S. Imamura; A. Yoshida; H. Tsutani; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 19 KB